Pathstone Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.98M Sell
2025
Q1
$1.7M Buy
2024
Q4
$1.45M Sell
2024
Q3
$1.72M Buy
2024
Q2
$1.37M Buy
2024
Q1
$577K Buy
2023
Q4
$552K Buy